Position in RCKT
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$2,380,059
New position
Shares Held
664,821
first reported quarter
Ownership
0.609%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Aberdeen Group plc holds $1,803,580,461 across 84 Biotechnology names. RCKT ranks #74 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
233,480 | $104,258,157 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,344 | $93,755,226 | |
| 3 | IMUX |
Immunic, Inc.
|
8,243,941 | $91,507,745 | |
| 4 | QURE |
uniQure N.V.
|
5,306,386 | $86,759,411 | |
| 5 | MANE |
Veradermics, Inc
|
1,054,660 | $66,601,779 | |
| 6 | ARGX |
Argenx SE
|
82,106 | $59,957,906 | |
| 7 | PCVX |
Vaxcyte, Inc.
|
978,969 | $56,887,888 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
172,484 | $55,572,619 |
All Filings in RCKT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,380,059 | 664,821 | Shares | Defined | 2026-04-29 | |
| No filing history on record for this holder in this stock. | ||||||